ProMIS Neurosciences logo

ProMIS Neurosciences

PMN | NASDAQ
Chart Builder DCF Calculator
$3.31
+$0.02 (+0.61%)
At close: Nov 16, 2026, 4:00 PM ET
$3.20
-$0.11 (-3.32%)
After-hours: Nov 16, 2026, 7:48 PM ET
+0.61%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
24.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #947/1021 (Top 93%)

Key Statistics

Market Data

Market Cap $29.78M
1D Range
3.15 3.49
52W Range
3.00 24.79

Valuation (TTM)

PE -0.35
PB 0.71
EV/EBITDA 0.36

Valuation (NTM)

Forward PE N/A
Forward PEG 0.00
Price Target $31.00
Loading financial charts...

Profile

ProMIS Neurosciences, Inc. is a Canadian biotechnology firm dedicated to creating targeted therapeutic solutions for debilitating neurodegenerative conditions such as Alzheimer's disease (AD), amyotro...

Sector Healthcare
Industry Biotechnology
Employees 11
IPO Date Jan 10, 2007
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
4
Consensus
Buy
Price Target
$31.00
Upside
+836.56%
Buy (4)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.